Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCMA”

373 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 373 results

Testing effectiveness (Phase 2)Looking for participantsNCT06799611
What this trial is testing

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)Treatment
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)UnknownNCT04714593
What this trial is testing

Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia， B-Cell
Shanxi Province Cancer Hospital 24
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Early research (Phase 1)UnknownNCT03706547
What this trial is testing

Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma Progression
Peng Liu 20
Early research (Phase 1)Looking for participantsNCT06375044
What this trial is testing

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Very early researchNot Yet RecruitingNCT07234721
What this trial is testing

SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 9
Not applicableNot Yet RecruitingNCT06769555
What this trial is testing

BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy

Who this might be right for
AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)+1 more
Polina Stepensky 60
Early research (Phase 1)Not Yet RecruitingNCT05976555
What this trial is testing

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 30
Very early researchWithdrawnNCT06926985
What this trial is testing

An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Jieyang People's Hospital
Very early researchLooking for participantsNCT06775912
What this trial is testing

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

Who this might be right for
SLESystemic SclerosisIIM+4 more
Nanjing Bioheng Biotech Co., Ltd. 18
Early research (Phase 1)Study completedNCT05182073
What this trial is testing

FT576 in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma
Fate Therapeutics 31
Very early researchNot Yet RecruitingNCT07266337
What this trial is testing

CD19/BCMA CAR-T for SLE

Who this might be right for
SLE - Systemic Lupus Erythematosus
Chengdu Ucello Biotechnology Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05972135
What this trial is testing

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 100
Testing effectiveness (Phase 2)Looking for participantsNCT06759181
What this trial is testing

Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 20
Testing effectiveness (Phase 2)UnknownNCT03271632
What this trial is testing

Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shenzhen Geno-Immune Medical Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT03758417
What this trial is testing

LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nanjing Legend Biotech Co. 123
Very early researchLooking for participantsNCT07530380
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaUCART
The Second Hospital of Anhui Medical University 15
Not applicableLooking for participantsNCT05106387
What this trial is testing

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Who this might be right for
Chronic Kidney Disease (CKD)
Regeneron Pharmaceuticals 20
Early research (Phase 1)Ended earlyNCT03502577
What this trial is testing

BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 19
Load More Results